Pulike Biological Engineering, Inc.

Rachunek Zysków i Strat


Finanse
Rachunek zysków i strat
Bilans
Przepływy pieniężne
Prognozy
Statystyki
Dywidendy
Rekomendacje
Modele wyceny
Wskaźniki
Analiza techniczna



index 0 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15
Rok finansowy 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Przychód (mln) 266 292 413 418 472 476 478 583 530 608 663 929 1,099 1,228 1,253 1,043
Przychód Δ r/r 0.0% 9.7% 41.1% 1.2% 13.1% 0.8% 0.5% 22.0% -9.1% 14.8% 9.1% 40.0% 18.3% 11.8% 2.0% -16.8%
Marża brutto 72.3% 71.3% 69.2% 71.2% 73.6% 75.0% 72.7% 71.3% 68.3% 67.1% 61.2% 64.3% 65.4% 62.8% 61.0% 61.1%
EBIT (mln) 109 93 132 142 169 158 154 183 108 137 107 247 285 183 193 98
EBIT Δ r/r 0.0% -14.8% 42.4% 7.2% 19.1% -6.8% -2.1% 18.6% -41.1% 26.7% -21.8% 130.7% 15.4% -35.6% 5.4% -49.3%
EBIT (%) 40.9% 31.8% 32.1% 34.0% 35.8% 33.1% 32.3% 31.4% 20.4% 22.5% 16.1% 26.6% 25.9% 14.9% 15.4% 9.4%
Koszty finansowe (mln) 2 1 5 4 0 1 5 4 4 0 1 0 0 1 1 0
EBITDA (mln) 113 97 137 180 220 193 181 201 131 210 176 326 343 277 317 221
EBITDA(%) 42.4% 33.3% 33.2% 43.0% 46.6% 40.6% 37.8% 34.5% 24.7% 34.5% 26.5% 35.1% 31.3% 22.6% 25.3% 21.2%
Podatek (mln) 16 20 22 22 29 27 27 33 19 18 8 32 40 10 20 6
Zysk Netto (mln) 93 84 115 129 163 140 142 188 114 136 109 228 244 168 175 93
Zysk netto Δ r/r 0.0% -9.5% 37.4% 12.0% 26.0% -13.9% 1.1% 32.6% -39.3% 18.8% -19.4% 108.5% 7.2% -31.3% 4.0% -46.8%
Zysk netto (%) 34.8% 28.7% 28.0% 30.9% 34.5% 29.5% 29.6% 32.2% 21.5% 22.3% 16.5% 24.5% 22.2% 13.7% 13.9% 8.9%
EPS 0.39 0.35 0.48 0.54 0.68 0.59 0.49 0.59 0.36 0.42 0.34 0.72 0.78 0.54 0.5 0.27
EPS (rozwodnione) 0.39 0.35 0.48 0.54 0.68 0.59 0.49 0.59 0.36 0.42 0.34 0.72 0.78 0.54 0.5 0.27
Ilośc akcji (mln) 240 240 240 239 240 240 289 319 317 321 321 316 315 322 349 344
Ważona ilośc akcji (mln) 240 240 240 239 240 240 289 319 317 323 321 316 315 322 349 344
Waluta CNY CNY CNY CNY CNY CNY CNY CNY CNY CNY CNY CNY CNY CNY CNY CNY